Use the keywords feature with a free QxMD account.
Use Read by QxMD to access full text via your institution or open access sources.
Read also provides personalized recommendations to keep you up to date in your field.
Existing User
Sign InNew to Read
Sign Up#1
JOURNAL ARTICLE
Winston W S Fung, Ryan K-H Sze, Cheuk-Chun Szeto, Kai-Ming Chow
RATIONALE & OBJECTIVE: Staphylococcus lugdunensis ( S lugdunensis ) is a coagulase-negative staphylococcus species that has been increasingly recognized to cause serious infections with virulence resembling Staphylococcus aureu s ( S aureus ). No studies have evaluated the characteristics and outcomes of patients with S lugdunensis peritoneal dialysis-related peritonitis compared with those with S aureus peritonitis. We aim to evaluate the clinical course of peritonitis as caused by these organisms...
May 2024: Kidney medicine
#2
JOURNAL ARTICLE
Jie Liu, Shuang Li, Fan Yang, Tianyu Li, Rui Li, Yousuf Waheed, Chen Meng, Shulin Li, Kun Liu, Yanshan Tong, Haisheng Xu, Chuankuo Tian, Xinglei Zhou
BACKGROUND/AIMS: Roxadustat, an oral medication for treating renal anemia, is a hypoxia-inducible factor prolyl hydroxylase inhibitor used for regulating iron metabolism and promoting erythropoiesis. To investigate the efficacy and safety of roxadustat in patients undergoing peritoneal dialysis (PD) with erythropoietin hyporesponsiveness. METHODS: Single-center, retrospective study, 81 PD patients (with erythropoietin hyporesponsiveness) were divided into the roxadustat group (n = 61) and erythropoiesis-stimulating agents (ESAs) group (n = 20)...
April 23, 2024: Korean Journal of Internal Medicine
#3
JOURNAL ARTICLE
Tuncay Sahutoglu, Ramazan Danis, Irem Pembegul, Ilyas Ozturk, Can Huzmeli, Murat Tugcu, Ebru Gok Oguz, Feyza Bora, Mahmud Islam, Yavuz Ayar, Zulfikar Yilmaz, Derya Basak Tanburoglu, Fatih Genc, Mehmet Emin Bindal, Serhan Tuglular, Rumeyza Kazancioglu
INTRODUCTION: Peritoneal dialysis (PD) remains understudied in disaster nephrology. This retrospective multicenter study explores the experiences of PD survivors following the February 6, 2023, Kahramanmaraş Earthquake. METHODS: Adult PD patients from 11 affected cities were analyzed to assess challenges faced during and postearthquake, alongside clinical outcomes. RESULTS: Among 101 participants (median age: 45 years, median PD duration: 24 months), 57 were female, with 79 on continuous ambulatory PD...
April 22, 2024: Therapeutic Apheresis and Dialysis
#4
JOURNAL ARTICLE
Pyogenic liver abscesses in peritoneal dialysis patients: A single-centre retrospective case series.
Regina Shaoying Lim, Yong Pey See
Peritoneal dialysis (PD)-related infection rates have improved, but serious complications such as liver abscesses remain an issue, posing unique management challenges including safety of continuing PD versus early PD catheter removal. Current literature describing this is unfortunately limited. This study aims to describe the characteristics, management and outcomes of liver abscesses in PD patients from a retrospective review of prevalent PD patients on follow-up at Tan Tock Seng Hospital between 1st January 2016 and 30th June 2021...
April 21, 2024: Peritoneal Dialysis International
#5
EDITORIAL
Antoine Lanot, Annabel Boyer, Thierry Lobbedez, Clémence Béchade
No abstract text is available yet for this article.
April 21, 2024: Peritoneal Dialysis International
#6
(no author information available yet)
No abstract text is available yet for this article.
April 21, 2024: Peritoneal Dialysis International
#7
JOURNAL ARTICLE
Naoto Okubo, Tatsuya Suwabe, Masayuki Yamanouchi, Daisuke Ikuma, Hiroki Mizuno, Yuki Oba, Katsuyuki Miki, Takayoshi Yokoyama, Yasuo Ishii, Naoki Sawa, Yuki Nakamura, Hisashi Takaya, Yoshifumi Ubara
A 49-year-old man was admitted with peritonitis nine months after starting continuous ambulatory peritoneal dialysis (CAPD) for kidney failure. Ceftazidime and cefazolin were started. Peritoneal dialysate culture was negative for bacteria, but antibiotic treatment was continued because peritonitis improved. Twenty days later, the patient was discharged with no signs of peritonitis. However, 40-day culture of the original peritoneal dialysate detected Mycobacterium tuberculosis, and peritonitis recurred, leading to readmission...
April 21, 2024: CEN Case Reports
#8
JOURNAL ARTICLE
Xuerui Yang, Jun Yang, Youjia Zeng, Ling Peng, Xingzheng Liu, Jinying Mo, Taifen Wang, Yutong Yao, Yihou Zheng, Gaofeng Song
OBJECTIVE: Cardiovascular disease (CVD) represents the primary cause of mortality in patients afflicted with end-stage renal disease and undergoing peritoneal dialysis (PD) treatment. Galectin-3 (Gal-3), a molecule known to exhibit a correlation with CVD mortality garners considerable interest. The objective of this study was to explore the potential association between serum Gal-3 levels and other CVD risk factors among PD patients. METHODS: In this cross-sectional study, a total of 114 PD patients with a minimum of 3 months of PD treatment were enrolled...
April 20, 2024: Clinical and Experimental Nephrology
#9
JOURNAL ARTICLE
Caroline M Hsu, Nien Chen Li, Eduardo K Lacson, Daniel E Weiner, Susan Paine, Karen Majchrzak, Christos Argyropoulos, Maria-Eleni Roumelioti, V Shane Pankratz, Dana Miskulin, Harold J Manley, Page Salenger, Doug Johnson, H Keith Johnson, Antonia Harford
RATIONALE & OBJECTIVE: Reasons for transfer from peritoneal dialysis (PD) to hemodialysis (HD) remain incompletely understood. Among incident and prevalent patients receiving PD, we evaluated the association between prior treatment with HD and PD technique survival. STUDY DESIGN: Retrospective cohort study. SETTING & PARTICIPANTS: Adults who initiated PD at a Dialysis Clinic, Inc. (DCI) outpatient facility between January 1, 2010 and September 30, 2019...
April 17, 2024: American Journal of Kidney Diseases
#10
JOURNAL ARTICLE
Rudolph A Rodriguez, Matthew A Sparks, Paul T Conway, Anamika Gavhane, Siddharta Reddy, Linda Awdishu, Sana Waheed, Sandra Davidson, Deborah B Adey, Janice P Lea, John C Lieske, Furman S McDonald
In 1988, the American Board of Internal Medicine (ABIM) defined essential procedural skills in nephrology, and candidates for ABIM certification were required to present evidence of possessing the skills necessary for placement of temporary dialysis vascular access, hemodialysis, peritoneal dialysis, and percutaneous renal biopsy. In 1996, continuous renal replacement therapy was added to the list of nephrology requirements. These procedure requirements have not been modified since 1996 while the practice of nephrology has changed dramatically...
April 17, 2024: American Journal of Kidney Diseases
#11
JOURNAL ARTICLE
Brittany A Boerstra, Rianne Boenink, Megan E Astley, Marjolein Bonthuis, Samar Abd ElHafeez, Federico Arribas Monzón, Anders Åsberg, Pazit Beckerman, Samira Bell, Aleix Cases Amenós, Pablo Castro de la Nuez, Marc A G J Ten Dam, Alicja Debska-Slizien, Nikola Gjorgjievski, Rebecca Giudotti, Jaakko Helve, Kristine Hommel, Alma Idrizi, Ólafur S Indriðason, Faiçal Jarraya, Julia Kerschbaum, Kirill S Komissarov, Nadiia Kozliuk, Milica Kravljaca, Mathilde Lassalle, Johan M De Meester, Mai Ots-Rosenberg, Zoe Plummer, Danilo Radunovic, Olena Razvazhaieva, Halima Resic, Olga Lucía Rodríguez Arévalo, Carmen Santiuste de Pablos, Nurhan Seyahi, María Fernanda Slon-Roblero, Maria Stendahl, Miloreta Tolaj-Avdiu, Sara Trujillo-Alemán, Ieva Ziedina, Edita Ziginskiene, Alberto Ortiz, Kitty J Jager, Vianda S Stel, Anneke Kramer
BACKGROUND: The European Renal Association (ERA) Registry collects data on kidney replacement therapy (KRT) in patients with end-stage kidney disease (ESKD). This paper is a summary of the ERA Registry Annual Report 2021, including a comparison across treatment modalities. METHODS: Data was collected from 54 national and regional registries from 36 countries, of which 35 registries from 18 countries contributed individual patient data and 19 registries from 19 countries contributed aggregated data...
February 2024: Clinical Kidney Journal
#12
JOURNAL ARTICLE
Momoko Hirata, Kiyonori Ito, Susumu Ookawara, Keisuke Tanno, Junki Morino, Saori Minato, Yuko Mutsuyoshi, Taisuke Kitano, Keiji Hirai, Yoshiyuki Morishita
INTRODUCTION: Many patients with chronic kidney disease (CKD), including peritoneal dialysis (PD), have sarcopenia. It is important to evaluate muscle mass to prevent sarcopenia in the field of CKD management. Recently, muscle mass assessment using psoas muscle evaluated by computed tomography (CT) has been reported in patients undergoing hemodialysis. However, few clinical studies have investigated the clinical factors associated with the evaluation of psoas muscle in patients undergoing PD...
March 2024: Curēus
#13
JOURNAL ARTICLE
Wenyue Ma, Hongjie Gao, Mengmeng Chang, Zhiyi Lu, Ding Li, Chen Ding, Dan Bi, Fengyin Sun
OBJECTIVE: This study was conducted to explore the risk factors for the prognosis and recurrence of ureteropelvic junction obstruction (UPJO). METHODS: The correlation of these variables with the prognosis and recurrence risks was analyzed by binary and multivariate logistic regression. Besides, a nomogram was constructed based on the multivariate logistic regression calculation. After the model was verified by the C-statistic, the ROC curve was plotted to evaluate the sensitivity of the model...
2024: Frontiers in Pediatrics
#14
JOURNAL ARTICLE
Steve Biko Tobada, Valérie Chatelet, Clemence Bechade, Antoine Lanot, Annabel Boyer, Cécile Couchoud, Fatouma Toure, Sabrina Boime, Thierry Lobbedez, Mathilde Beaumier
BACKGROUND: Social deprivation is associated with lower peritoneal dialysis (PD) uptake. This study was carried out to evaluate the role of social deprivation on the outcome of PD. METHODS: This was a retrospective study of data extracted from the Renal Epidemiology and Information Network registry for patients older than 18 years who started PD in metropolitan France between 1 January 2017 and 30 June 2018. The end of the observation period was 31 December 2020...
April 17, 2024: Peritoneal Dialysis International
#15
JOURNAL ARTICLE
Elias Hajj, Marijke Awouters, Melodie Mosca, Sacha Flammier, Sarra Rachedi, Justine Bacchetta, Aurelie De Mul, Bruno Ranchin
Kidney failure has a negative impact on both children and families' quality of life (QOL). We evaluated the burden of home peritoneal dialysis (PD) using two local questionnaires and the French version of PedsQL3.0 end-stage kidney disease module and family impact module. Data are expressed as median (min-max). We reviewed the charts of 12 patients, at a median age of 8.8 (1.2-16.7) years, undergoing maintenance PD for 8 (1-42) months. Parathyroid hormone and haemoglobin levels were 215 (17-606) ng/L and 117 (104-141) g/L, respectively...
April 17, 2024: Peritoneal Dialysis International
#16
JOURNAL ARTICLE
Luke C Wilson, Jacob Ward, Daniel F B Wright, Suetonia C Green, Sophie L Stocker, Tracey L Putt, John B W Schollum, Robert J Walker
Gout affects 15%-30% of individuals with advanced kidney disease. Allopurinol which is rapidly and extensively metabolised to an active metabolite, oxypurinol, is the most commonly prescribed urate-lowering therapy. Oxypurinol is almost entirely eliminated by the kidneys (>95%) and has an elimination half-life of 18-30 h in those with normal kidney function. However, oxypurinol pharmacokinetics are poorly understood in individuals with kidney failure on peritoneal dialysis. This study characterised the elimination of oxypurinol and urate in people with gout receiving peritoneal dialysis...
April 16, 2024: Nephrology
#17
JOURNAL ARTICLE
Maurizio Bossola, Barbara Picconi
Chronic kidney disease (CKD) patients have an increased risk for cognitive impairment compared to the general population. The risk is much higher in CKD patients who progress to end-stage kidney disease (ESKD) and require hemodialysis or peritoneal dialysis. Multiple factors may contribute to cognitive impairment in CKD patients and in patients on chronic dialysis. However, the observation that, after kidney transplantation, there is an improvement in several cognitive performance markers and that some structural and functional brain abnormalities may improve suggests that cognitive deficits in patients on dialysis may be at least partially reversible...
April 16, 2024: Journal of Nephrology
#18
JOURNAL ARTICLE
Shizheng Guo, Liming Yang, Xueyan Zhu, Xiaoxuan Zhang, Zhanshan Sun, Lingfei Meng, Yangwei Wang, Jian Li, Siyu Cheng, Xiaohua Zhuang, Wenpeng Cui
BACKGROUND: The first six months of therapy represents a high-risk period for peritoneal dialysis (PD) failure. The risk of death in the first six months is higher for older patients treated with urgent-start PD (USPD). However, there are still gaps in research on mortality and risk factors for death in this particular group of patients. We aimed to investigate mortality rates and risk factors for death in older patients with end-stage renal disease (ESRD) receiving USPD within and after six months of therapy...
April 15, 2024: BMC Geriatrics
#19
JOURNAL ARTICLE
Jun-Li Zhao, Lin Zhao, Qiu-Nan Zhan, Miao Liu, Ting Zhang, Wen-Wen Chu
OBJECTIVE: Peritoneal fibrosis (PF) is the main cause of declining efficiency and ultrafiltration failure of the peritoneum, which restricts the long-term application of peritoneal dialysis (PD). This study aimed to investigate the therapeutic effects and mechanisms of bone marrow mesenchymal stem cells-derived exosomes (BMSC-Exos) on PF in response to PD. METHODS: Small RNA sequencing analysis of BMSC-Exos was performed by second-generation sequencing. C57BL/6J mice were infused with 4...
April 16, 2024: Current Medical Science
#20
JOURNAL ARTICLE
Hai-Tao Xing, Feng-Mei Ding, Jia-Qi Li, Qian-Yi Zhou, Hong-Tao Yang
Network pharmacology was employed to probe into the mechanism of Fushen Granules in treating peritoneal dialysis-rela-ted peritonitis(PDRP) in rats. The main active components of Fushen Granules were searched against the Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform, and their targets were predicted. PDRP-related targets were retrieved from DisGeNET and other databases. The common targets shared by the drug and the disease were identified by the online tool, and protein-protein interaction(PPI) network of the common targets...
March 2024: Zhongguo Zhong Yao za Zhi, Zhongguo Zhongyao Zazhi, China Journal of Chinese Materia Medica
Make the most of Read.
Download the mobile app.
Download the mobile app.
Fetching more papers... 
